Spyre Therapeutics Inc.(SYRE)— 技术面状态
数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +6.3% vs the 50-day and +29.9% vs the 200-day average, 13.3% below the 52-week high and +351.7% off the 52-week low. Computed from daily closes.
Ranked #23 on today’s Directional Flow — Top scores list (scan of 2026-11-02).
均线状态
- 相对20日均线+8.2%
- 相对50日均线+6.3%
- 相对200日均线+29.9%
- 52周区间低于52周高点13.3% · 高于52周低点351.7%
- 连续走势连续3个交易日下跌
- 50日均线交叉股价向上穿越50日均线(5个交易日前)
- 随机指标%K 79.2 · %D 91.9
FAQ · from the current data · as of 2026-11-02
Quick answers
SYRE当前的Closelook信号是什么?
Uptrend stack intact — Trades +6.3% vs the 50-day and +29.9% vs the 200-day average, 13.3% below the 52-week high and +351.7% off the 52-week low. Computed from daily closes.(截至2026-11-02;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
SYRE目前是否位于50日和200日均线上方?
截至2026-11-02,Spyre Therapeutics Inc.位于50日均线上方(+6.3%),200日均线上方(+29.9%);距20日均线+8.2%。
SYRE距52周高点有多远?
截至2026-11-02,低于52周高点13.3%,高于52周低点351.7%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry